Clinical Trial Update: Closed-loop Control of Glucose Levels (Artificial Pancreas) for 24 Hours in Adults With Type 2 Diabetes Under Intensive Insulin Therapy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated closed-loop glucose control (artificial pancreas) for 24 hours in adults with Type 2 diabetes on intensive insulin therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Institut de Recherches Cliniques de Montreal | Conditions: Type 2 Diabetes | Phase 2 | Status: COMPLETED